All Releases
View Summary Celldex Therapeutics to Present Antibody-Drug Conjugate CDX-014 Preclinical Proof of Concept Data at AACR 2014
Apr 3, 2014
PDF 15.0 KB Add to Briefcase
View Summary Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy
Mar 3, 2014
PDF 35.0 KB Add to Briefcase
View Summary Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call
Feb 25, 2014
PDF 15.1 KB Add to Briefcase
View Summary Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference
Feb 6, 2014
PDF 15.0 KB Add to Briefcase
View Summary Celldex's CDX-301 in Combination with Mozobil(R) Increases Hematopoietic Stem Cell Mobilization and Results in Improved Transplantation of Mobilized Cells in Preclinical Studies; Results Presented at ASH 2013
Dec 10, 2013
PDF 20.1 KB Add to Briefcase
View Summary Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares
Dec 9, 2013
PDF 19.4 KB Add to Briefcase
View Summary Celldex Therapeutics Prices Public Offering of Common Stock
Dec 4, 2013
PDF 19.3 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Proposed Public Offering of Common Stock
Dec 3, 2013
PDF 18.7 KB Add to Briefcase
View Summary Celldex Therapeutics Initiates METRIC, an Accelerated Approval Study of Glembatumumab Vedotin in Patients with Triple Negative Breast Cancer
Dec 2, 2013
PDF 63.0 KB Add to Briefcase
View Summary Celldex Announces Upcoming Presentation at the Deutsche Bank 2013 BioFEST
Nov 27, 2013
PDF 14.9 KB Add to Briefcase
View Summary Celldex Therapeutics' Rindopepimut Demonstrates Promising Clinical Activity in Patients with EGFRvIII-positive Recurrent Glioblastoma at SNO
Nov 24, 2013
PDF 32.6 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Publication of Preliminary Data from the Phase 2 ReACT Study to be Presented at the 18th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
Nov 11, 2013
PDF 20.6 KB Add to Briefcase
View Summary Celldex Reports Third Quarter 2013 Financial Results
Nov 8, 2013
PDF 28.9 KB Add to Briefcase
View Summary Celldex Therapeutics' CDX-1127 Well Tolerated and Demonstrates Anti-Tumor Activity in Phase 1 Dose-Escalation Study
Nov 7, 2013
PDF 25.7 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer and Society of Neuro-Oncology Annual Meetings
Oct 21, 2013
PDF 17.5 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Upcoming Presentation at the Leerink Swann Rare Disease Roundtable
Sep 26, 2013
PDF 15.1 KB Add to Briefcase
View Summary Celldex Announces Expansion of Phase 2 ReACT Study in Recurrent Glioblastoma
Aug 12, 2013
PDF 21.2 KB Add to Briefcase
View Summary Celldex Reports Second Quarter 2013 Financial Results
Aug 6, 2013
PDF 28.8 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Issuance of Seminal Patent for CD27 Agonists
Jul 10, 2013
PDF 20.2 KB Add to Briefcase
View Summary Celldex Therapeutics Initiates Pilot Study in Dense Deposit Disease
Jul 1, 2013
PDF 61.6 KB Add to Briefcase
Showing 81-100 of 142 Page: 1 2 3 4 5 6 7 8  Previous 20 | Next 20
Showing 81-100 of 142
Page: 1 2 3 4 5 6 7 8
 Previous 20 | Next 20
Add to Briefcase = add release to Briefcase